Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases

CD44v6-derived cyclic peptides for treating cancers and angiogenesis related diseases

US Patent 10703796 · Granted Jul 7, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substrates for III-nitride epitaxy2025
Methods of treating cut stem tobacco material2025
Double-labeled probe for molecular imaging and use thereof2024
18F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use2024
Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agent2024
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for th2024
Double-labeled probe for molecular imaging and use thereof2023
Double-labeled probe for molecular imaging and use thereof2022
Cyclic NTCP-targeting peptides and their uses as entry inhibitors2022
Methylglyoxal-scavenging cyclic peptides and their use for the prevention and tr2021
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for th2021
Double-labeled probe for molecular imaging and use thereof2021